CSBR vs LYFT · P/E 16, rev $56.9M vs P/E 108, rev $5.79B
Champions Oncology Inc (CSBR) versus LYFT Inc (LYFT) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
LYFT Inc (LYFT) is a software - application company listed on US. It is led by David Risher.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported LYFT revenue for 2024-12-31 was $5.79B. Net income was $22.8M. Revenue was up 31.4% from 2023-12-31 to 2024-12-31. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
Not investment advice. Open the CSBR and LYFT stock pages for the full models.
Not investment advice.